DermTopic: Psoriasis

Filter Your Results

 

News

 

PsA Patients Failing Anti-TNF Drugs May Do Well on Taltz

New data show that Taltz (ixekizumab) improved the signs and symptoms of active psoriatic arthritis (PsA) in patien…

Tildrakizumab Performs Well in Two Phase 3 Psoriasis Studies

Two Phase 3 trials show that tildrakizumab is efficacious and well-tolerated in patients with moderate-to-severe chronic…

Game Change: New Handheld Tissue Scanner Can See Below Surfa…

A new handheld tissue scanner allows dermatologists to look below the surface of skin in psoriasis patients and can…

FDA Clears Clarify Medical Core Technology for At-home UVB P…

The US Food and Drug Administration has cleared the Clarify Medical Phototherapy System for marketing, and the new smart…

Largest Psoriasis Meta-Analysis to Date Yields New Genetic C…

A new meta -analysis identifies 16 additional genetic markers that may help researchers get closer to understanding how …

Sun Pharma Announces US FDA Filing Acceptance of Biologics L…

The U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for Sun Pharma’s …

Tweaking TWEAK May Cool Inflammation in Pso and AD

New research pinpoints a common driver of skin inflammation in both psoriasis and atopic dermatitis. The findings, pu…

Valeant Dermatology Announces New Senior Leadership Team in …

Valeant Dermatology announced a new senior leadership team, led by Bill Humphries, executive vice president and group ch…

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.